Pollhammer Michael S, Duscher Dominik, Schmidt Manfred, Huemer Georg M
Michael S Pollhammer, Dominik Duscher, Manfred Schmidt, Georg M Huemer, Section of Plastic, Aesthetic and Reconstructive Surgery, Department of General Surgery, Kepler University Hospital Linz, 4020 Linz, Austria.
World J Clin Oncol. 2016 Feb 10;7(1):114-21. doi: 10.5306/wjco.v7.i1.114.
Breast cancer is a ubiquitous disease and one of the leading causes of death in women in western societies. With overall increasing survival rates, the number of patients who need post-mastectomy reconstruction is on the rise. Especially since its psychological benefits have been broadly recognized, breast reconstruction has become a key component of breast cancer treatment. Evolving from the early beginnings of breast reconstruction with synthetic implants in the 1960s, microsurgical tissue transfer is on the way to become the gold standard for post oncology restoration of the breast. Particularly since the advent of perforator based free flap surgery, free tissue transfer has become as safe option for breast reconstruction with low morbidity. The lower abdominal skin and subcutaneous fat tissue typically offer enough volume to create an aesthetically satisfying breast mound. Nowadays, the most commonly used flap from this donor site is the deep inferior epigastric artery perforator flap. If the lower abdomen is not available as a donor site, the gluteal area and thigh provide a number of flaps suitable for breast reconstruction. If the required breast volume is small, and there is enough tissue available on the upper medial thigh, then a transverse upper gracilis flap may be a practicable method to reconstruct the breast. In case of a higher amount of required volume, a gluteal artery perforator flap is the best choice. However, what is crucial in addition to selecting the best flap option for the individual patient is the timing of the operation. In patients with confirmed post-mastectomy radiation therapy, it is advisable to perform microvascular breast reconstruction only in a delayed fashion.
乳腺癌是一种普遍存在的疾病,也是西方社会女性主要死因之一。随着总体生存率的不断提高,需要乳房切除术后重建的患者数量在增加。特别是自从其心理益处得到广泛认可以来,乳房重建已成为乳腺癌治疗的关键组成部分。从20世纪60年代使用人工合成植入物进行乳房重建的早期开始发展,显微外科组织移植正逐渐成为肿瘤切除术后乳房修复的金标准。尤其是自从基于穿支的游离皮瓣手术出现以来,游离组织移植已成为一种低发病率的安全乳房重建选择。下腹皮肤和皮下脂肪组织通常能提供足够的体积来塑造一个美观的乳房隆起。如今,这个供区最常用的皮瓣是腹壁下深动脉穿支皮瓣。如果下腹不能作为供区,臀区和大腿提供了一些适合乳房重建的皮瓣。如果所需的乳房体积较小,且大腿内侧上部有足够的组织,那么股薄肌横行皮瓣可能是一种可行的乳房重建方法。如果所需体积较大,臀动脉穿支皮瓣是最佳选择。然而,除了为个体患者选择最佳皮瓣选项外,手术时机也至关重要。对于确诊需要进行乳房切除术后放疗的患者,建议仅在延迟期进行微血管乳房重建。